List of Tables
Table 1. Brucellosis Vaccines Market Trends
Table 2. Brucellosis Vaccines Market Drivers & Opportunity
Table 3. Brucellosis Vaccines Market Challenges
Table 4. Brucellosis Vaccines Market Restraints
Table 5. Global Brucellosis Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Brucellosis Vaccines Revenue Market Share by Company (2020-2025)
Table 7. Global Brucellosis Vaccines Sales Volume by Company (2020-2025) & (M Doses)
Table 8. Global Brucellosis Vaccines Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Brucellosis Vaccines Price by Company (2020-2025) & (USD/K Doses)
Table 10. Key Manufacturers Brucellosis Vaccines Manufacturing Base and Headquarters
Table 11. Key Manufacturers Brucellosis Vaccines Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Brucellosis Vaccines
Table 13. Global Brucellosis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucellosis Vaccines as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Brucellosis Vaccines Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Brucellosis Vaccines Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Brucellosis Vaccines Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Brucellosis Vaccines Sales Market Share in Value by Type (2020-2025)
Table 20. Global Brucellosis Vaccines Sales Market Share in Value by Type (2026-2031)
Table 21. Global Brucellosis Vaccines Sales Volume by Type: 2020 VS 2024 VS 2031 (M Doses)
Table 22. Global Brucellosis Vaccines Sales Volume by Type (2020-2025) & (M Doses)
Table 23. Global Brucellosis Vaccines Sales Volume by Type (2026-2031) & (M Doses)
Table 24. Global Brucellosis Vaccines Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Brucellosis Vaccines Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Brucellosis Vaccines Price by Type (2020-2025) & (USD/K Doses)
Table 27. Global Brucellosis Vaccines Price by Type (2026-2031) & (USD/K Doses)
Table 28. Global Brucellosis Vaccines Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Brucellosis Vaccines Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Brucellosis Vaccines Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Brucellosis Vaccines Sales Market Share in Value by Application (2020-2025)
Table 32. Global Brucellosis Vaccines Sales Market Share in Value by Application (2026-2031)
Table 33. Global Brucellosis Vaccines Sales Volume by Application: 2020 VS 2024 VS 2031 (M Doses)
Table 34. Global Brucellosis Vaccines Sales Volume by Application (2020-2025) & (M Doses)
Table 35. Global Brucellosis Vaccines Sales Volume by Application (2026-2031) & (M Doses)
Table 36. Global Brucellosis Vaccines Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Brucellosis Vaccines Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Brucellosis Vaccines Price by Application (2020-2025) & (USD/K Doses)
Table 39. Global Brucellosis Vaccines Price by Application (2026-2031) & (USD/K Doses)
Table 40. Global Brucellosis Vaccines Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Brucellosis Vaccines Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Brucellosis Vaccines Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Brucellosis Vaccines Sales Value by Region (2020-2025) & (%)
Table 44. Global Brucellosis Vaccines Sales Value by Region (2026-2031) & (%)
Table 45. Global Brucellosis Vaccines Sales Volume by Region (M Doses): 2020 VS 2024 VS 2031
Table 46. Global Brucellosis Vaccines Sales Volume by Region (2020-2025) & (M Doses)
Table 47. Global Brucellosis Vaccines Sales Volume by Region (2026-2031) & (M Doses)
Table 48. Global Brucellosis Vaccines Sales Volume by Region (2020-2025) & (%)
Table 49. Global Brucellosis Vaccines Sales Volume by Region (2026-2031) & (%)
Table 50. Global Brucellosis Vaccines Average Price by Region (2020-2025) & (USD/K Doses)
Table 51. Global Brucellosis Vaccines Average Price by Region (2026-2031) & (USD/K Doses)
Table 52. Key Countries/Regions Brucellosis Vaccines Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Brucellosis Vaccines Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Brucellosis Vaccines Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Brucellosis Vaccines Sales Volume, (2020-2025) & (M Doses)
Table 56. Key Countries/Regions Brucellosis Vaccines Sales Volume, (2026-2031) & (M Doses)
Table 57. Jinyu Company Information
Table 58. Jinyu Introduction and Business Overview
Table 59. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 60. Jinyu Brucellosis Vaccines Product Offerings
Table 61. Jinyu Recent Development
Table 62. Colorado Serum Company Information
Table 63. Colorado Serum Introduction and Business Overview
Table 64. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 65. Colorado Serum Brucellosis Vaccines Product Offerings
Table 66. Colorado Serum Recent Development
Table 67. Boehringer Ingelheim Company Information
Table 68. Boehringer Ingelheim Introduction and Business Overview
Table 69. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 70. Boehringer Ingelheim Brucellosis Vaccines Product Offerings
Table 71. Boehringer Ingelheim Recent Development
Table 72. Biogenesis-Bago Company Information
Table 73. Biogenesis-Bago Introduction and Business Overview
Table 74. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 75. Biogenesis-Bago Brucellosis Vaccines Product Offerings
Table 76. Biogenesis-Bago Recent Development
Table 77. Vetal Company Company Information
Table 78. Vetal Company Introduction and Business Overview
Table 79. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 80. Vetal Company Brucellosis Vaccines Product Offerings
Table 81. Vetal Company Recent Development
Table 82. CZ Veterinaria Company Information
Table 83. CZ Veterinaria Introduction and Business Overview
Table 84. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 85. CZ Veterinaria Brucellosis Vaccines Product Offerings
Table 86. CZ Veterinaria Recent Development
Table 87. SYVA Laboratorios Company Information
Table 88. SYVA Laboratorios Introduction and Business Overview
Table 89. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 90. SYVA Laboratorios Brucellosis Vaccines Product Offerings
Table 91. SYVA Laboratorios Recent Development
Table 92. Indian Immunologicals Company Information
Table 93. Indian Immunologicals Introduction and Business Overview
Table 94. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 95. Indian Immunologicals Brucellosis Vaccines Product Offerings
Table 96. Indian Immunologicals Recent Development
Table 97. Qilu Company Information
Table 98. Qilu Introduction and Business Overview
Table 99. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 100. Qilu Brucellosis Vaccines Product Offerings
Table 101. Qilu Recent Development
Table 102. Tecnovax Company Information
Table 103. Tecnovax Introduction and Business Overview
Table 104. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 105. Tecnovax Brucellosis Vaccines Product Offerings
Table 106. Tecnovax Recent Development
Table 107. Hester Biosciences Company Information
Table 108. Hester Biosciences Introduction and Business Overview
Table 109. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 110. Hester Biosciences Brucellosis Vaccines Product Offerings
Table 111. Hester Biosciences Recent Development
Table 112. Zoetis Company Information
Table 113. Zoetis Introduction and Business Overview
Table 114. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 115. Zoetis Brucellosis Vaccines Product Offerings
Table 116. Zoetis Recent Development
Table 117. Onderstepoort Biological Company Information
Table 118. Onderstepoort Biological Introduction and Business Overview
Table 119. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 120. Onderstepoort Biological Brucellosis Vaccines Product Offerings
Table 121. Onderstepoort Biological Recent Development
Table 122. Instituto Rosenbusch Company Information
Table 123. Instituto Rosenbusch Introduction and Business Overview
Table 124. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 125. Instituto Rosenbusch Brucellosis Vaccines Product Offerings
Table 126. Instituto Rosenbusch Recent Development
Table 127. Ceva Sante Animale Company Information
Table 128. Ceva Sante Animale Introduction and Business Overview
Table 129. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 130. Ceva Sante Animale Brucellosis Vaccines Product Offerings
Table 131. Ceva Sante Animale Recent Development
Table 132. Calier & Biologicos Laverlam Company Information
Table 133. Calier & Biologicos Laverlam Introduction and Business Overview
Table 134. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 135. Calier & Biologicos Laverlam Brucellosis Vaccines Product Offerings
Table 136. Calier & Biologicos Laverlam Recent Development
Table 137. Biovet Company Information
Table 138. Biovet Introduction and Business Overview
Table 139. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 140. Biovet Brucellosis Vaccines Product Offerings
Table 141. Biovet Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Brucellosis Vaccines Downstream Customers
Table 145. Brucellosis Vaccines Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Brucellosis Vaccines Product Picture
Figure 2. Global Brucellosis Vaccines Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Brucellosis Vaccines Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Brucellosis Vaccines Sales Volume (2020-2031) & (M Doses)
Figure 5. Global Brucellosis Vaccines Sales Price (2020-2031) & (USD/K Doses)
Figure 6. Brucellosis Vaccines Report Years Considered
Figure 7. Global Brucellosis Vaccines Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Brucellosis Vaccines Players Sales Volume Ranking (2024) & (M Doses)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Brucellosis Vaccines Revenue in 2024
Figure 10. Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. S19 Vaccine Picture
Figure 12. RB51 Vaccine Strain Picture
Figure 13. Global Brucellosis Vaccines Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Brucellosis Vaccines Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Brucellosis Vaccines Sales Volume by Type (2020 VS 2024 VS 2031) & (M Doses)
Figure 16. Global Brucellosis Vaccines Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Brucellosis Vaccines Price by Type (2020-2031) & (USD/K Doses)
Figure 18. Product Picture of Cattle
Figure 19. Product Picture of Sheep
Figure 20. Product Picture of Others
Figure 21. Global Brucellosis Vaccines Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Brucellosis Vaccines Sales Value Market Share by Application, 2024 & 2031
Figure 23. Global Brucellosis Vaccines Sales Volume by Application (2020 VS 2024 VS 2031) & (M Doses)
Figure 24. Global Brucellosis Vaccines Sales Volume Market Share by Application, 2024 & 2031
Figure 25. Global Brucellosis Vaccines Price by Application (2020-2031) & (USD/K Doses)
Figure 26. North America Brucellosis Vaccines Sales Value (2020-2031) & (US$ Million)
Figure 27. North America Brucellosis Vaccines Sales Value by Country (%), 2024 VS 2031
Figure 28. Europe Brucellosis Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 29. Europe Brucellosis Vaccines Sales Value by Country (%), 2024 VS 2031
Figure 30. Asia Pacific Brucellosis Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Brucellosis Vaccines Sales Value by Region (%), 2024 VS 2031
Figure 32. South America Brucellosis Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 33. South America Brucellosis Vaccines Sales Value by Country (%), 2024 VS 2031
Figure 34. Middle East & Africa Brucellosis Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 35. Middle East & Africa Brucellosis Vaccines Sales Value by Country (%), 2024 VS 2031
Figure 36. Key Countries/Regions Brucellosis Vaccines Sales Value (%), (2020-2031)
Figure 37. Key Countries/Regions Brucellosis Vaccines Sales Volume (%), (2020-2031)
Figure 38. United States Brucellosis Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 39. United States Brucellosis Vaccines Sales Value by Type (%), 2024 VS 2031
Figure 40. United States Brucellosis Vaccines Sales Value by Application (%), 2024 VS 2031
Figure 41. Europe Brucellosis Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 42. Europe Brucellosis Vaccines Sales Value by Type (%), 2024 VS 2031
Figure 43. Europe Brucellosis Vaccines Sales Value by Application (%), 2024 VS 2031
Figure 44. China Brucellosis Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 45. China Brucellosis Vaccines Sales Value by Type (%), 2024 VS 2031
Figure 46. China Brucellosis Vaccines Sales Value by Application (%), 2024 VS 2031
Figure 47. Japan Brucellosis Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 48. Japan Brucellosis Vaccines Sales Value by Type (%), 2024 VS 2031
Figure 49. Japan Brucellosis Vaccines Sales Value by Application (%), 2024 VS 2031
Figure 50. South Korea Brucellosis Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 51. South Korea Brucellosis Vaccines Sales Value by Type (%), 2024 VS 2031
Figure 52. South Korea Brucellosis Vaccines Sales Value by Application (%), 2024 VS 2031
Figure 53. Southeast Asia Brucellosis Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 54. Southeast Asia Brucellosis Vaccines Sales Value by Type (%), 2024 VS 2031
Figure 55. Southeast Asia Brucellosis Vaccines Sales Value by Application (%), 2024 VS 2031
Figure 56. India Brucellosis Vaccines Sales Value, (2020-2031) & (US$ Million)
Figure 57. India Brucellosis Vaccines Sales Value by Type (%), 2024 VS 2031
Figure 58. India Brucellosis Vaccines Sales Value by Application (%), 2024 VS 2031
Figure 59. Brucellosis Vaccines Industrial Chain
Figure 60. Brucellosis Vaccines Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
